Related Experiment Video
Updated: Jun 8, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Prevention, diagnosis, and treatment of hypertensive heart disease
Vasiliki V Georgiopoulou1, Andreas P Kalogeropoulos, Paolo Raggi
1Emory University, Atlanta, GA 30322, USA.
Insights
Hypertensive heart disease involves cardiac changes due to high blood pressure. Renin-angiotensin system blockers are most effective for reversing left ventricular hypertrophy and improving outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiac Physiology
Background:
- Hypertensive heart disease (HHD) arises from chronic hypertension, causing myocardial structural and functional changes.
- The renin-angiotensin system significantly contributes to cardiac remodeling in HHD.
- Left ventricular hypertrophy (LVH) is a key manifestation of HHD, impacting prognosis.
Purpose of the Study:
- To review the role of antihypertensive therapy in managing HHD.
- To evaluate the effectiveness of different antihypertensive agents in regressing LVH.
- To highlight the importance of preventing myocardial remodeling for improved cardiac function.
Main Methods:
- Literature review of studies on hypertensive heart disease and left ventricular hypertrophy.
- Analysis of the impact of neurohormonal factors, specifically the renin-angiotensin system.
- Comparison of antihypertensive agents regarding their efficacy in LVH regression.
Main Results:
- Optimal antihypertensive therapy combined with lifestyle changes is crucial for HHD control.
- Regression of LVH is achievable and linked to better patient prognosis.
- Renin-angiotensin system blocking agents demonstrate the highest effectiveness in promoting LVH regression and reverse remodeling.
Conclusions:
- Early intervention and appropriate antihypertensive strategies are vital in managing HHD.
- Preventing myocardial remodeling before LVH onset offers greater prognostic benefits.
- Renin-angiotensin system inhibitors are the preferred agents for treating LVH in hypertensive patients.
Abstract:
Hypertensive heart disease (HHD), a result of long-standing hypertension, is characterized by changes in the myocardial structure and function in the absence of other primary cardiovascular abnormalities. Although increased blood pressure is the initiating stimulus, neurohormonal factors, particularly the renin-angiotensin system, play a key role in remodeling of cardiac chamber geometry and walls. Optimal antihypertensive therapy in the setting of therapeutic lifestyle changes is crucial in the prevention and control of HHD. Regression of left ventricular hypertrophy (LVH) is achievable and associated with improved prognosis. However, prevention of myocardial remodeling before LVH establishes would further increase the benefits to cardiac function and prognosis. Antihypertensive agents exhibit variable effectiveness in inducing LVH regression. Currently, renin-angiotensin system blocking agents seem to be the most effective approach for LVH regression and reverse remodeling in these patients.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension I: Introduction
